Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A. M. D., Karkkainen, M. J., Tainola, T.
, Pedersen, F. S., Sørensen, A. B., Kühle, A. V. D. A. & d'Amore, F. A. (2008).
Correlation between epstein-barr virus (EBV) RNA expression and vascular endothelial growth factor (VEGF) expression in different subtypes of peripheral T-cell lymphomas (PTCL) and prognostic implications. In
ANNALS OF ONCOLOGY (Vol. 19, pp. 113-113)
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A., Karkkainen, M. J., Tainola, T.
, Sørensen, A. B., Pedersen, F. S. & D'Amore, F. (2009).
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Leukemia & Lymphoma,
50(10), 1647-1660.
https://doi.org/10.1080/10428190903156729,
https://doi.org/10.1080/10428190903156729
Johnson, P., Federico, M., Fossa, A., O'Doherty, M., Roberts, T., Stevens, L., Smith, P., Kirkwood, A., Anghe, G., Trotman, J., Berkahn, L.
, D'Amore, F. A., Enblad, G., Luminari, S., Viney, Z., Radford, J. & Barrington, S. (2013).
Responses and chemotherapy dose adjustment determined by PET-CT imaging: First results from the international response adapted therapy in advanced hodgkin lymphoma (RATHL) study.
Hematological Oncology,
31, 138.
Johnson, PWM., Federico, M., Kirkwood, AA., Fossa, A., Berkahn, L., Carella, AM.
, D'Amore, F. A., Enblad, G., Franceschetto, A., Fulham, M., Luminari, S., O'Doherty, M., Patrick, P., Roberts, T., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. ... Barrington, SF. (2016).
Treatment adaptation guided by interim PET scan in advanced Hodgkin lymphoma.
The New England Journal of Medicine,
374(25), 2419-29.
https://doi.org/10.1056/NEJMoa1510093.Johnson, P., Federico, M., Kirkwood, A. A., Fossa, A., Berkahn, L., Carella, A.
, d'Amore, F., Enblad, G., Franceschetto, A., Fulham, M. J., Luminari, S., O'Doherty, M. J., Patrick, P., Roberts, T. H., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. N. ... Barrington, S. (2016).
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
The New England Journal of Medicine,
374(25), 2419-2429.
https://doi.org/10.1056/NEJMoa1510093Jepsen, J. R.
, d'Amore, F., Baandrup, U.
, Clausen, M. R., Gottschalck, E. & Aasted, B. (2009).
Aleutian mink disease virus and humans.
Emerging Infectious Diseases (Print Edition),
15(12), 2040-2.
https://doi.org/10.3201/eid1512.090514Jantunen, E., Relander, T., Lauritzsen, G., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Østenstad, B., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2011).
Intensive induction chemotherapy followed by autologous stem cell transplantation (ASCT) in patients with enteropathy-associated T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21), 3565.
Hybel, T. E., Vase, M. Ø., Maksten, E. F.
, Enemark, M. B., Lauridsen, K. L., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, d'Amore, F. & Ludvigsen, M. (2021).
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.
Acta Oncologica,
60(12), 1637-1642.
https://doi.org/10.1080/0284186X.2021.1973093
Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G.
, Hamilton-Dutoit, S., Obel, N.
, Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022).
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia & Lymphoma,
63(6), 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741
Hybel, T. E., Jensen, S. H., Rodrigues, M. A.
, Hybel, T. E., Pedersen, M. N., Qvick, S. H.
, Enemark, M. H., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2024).
Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia.
International Journal of Molecular Sciences ,
25(12), Article 6465.
https://doi.org/10.3390/ijms25126465
Hybel, T. E., Sørensen, E. F., Enemark, M. H., Hemmingsen, J. K., Simonsen, A. T., Lauridsen, K. L., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S., d'Amore, F., Hamilton-Dutoit, S., Stougaard, M., Vase, M. Ø. & Ludvigsen, M. (2024).
Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.
AIDS,
38(14), 1897-1906.
https://doi.org/10.1097/QAD.0000000000003996
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Berthelsen, A. K.
, Keiding, S., d'Amore, F. A., Boesen, A. M., Mikkelsen, L. R. & Specht, L. (2006).
Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Haematologica,
91, 482-9.
Hussmann, D., Starnawska, A., Kristensen, L.
, Daugaard, I., Thomsen, A.
, Kjeldsen, T., Hansen, C. S., Bybjerg-Grauholm, J.
, Dalsgaard Johansen, K., Ludvigsen, M., Kristensen, T., Larsen, T. S., Møller, M. B., Nyvold, C. G.
, Hansen, L. L. & Wojdacz, T. K. (2022).
IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.
Haematologica,
107(4), 877-886.
https://doi.org/10.3324/haematol.2021.278477
Honoré, B., Andersen, M. D., Wilken, D., Kamper, P., d'Amore, F., Hamilton-Dutoit, S. & Ludvigsen, M. (2022).
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
Cancers,
14(1), Article 247.
https://doi.org/10.3390/cancers14010247
Holst, J. M., Ludvigsen, M., Hamilton Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B.
, Steiniche, T., Rabinovich, G. A.
, d'Amore, F. A. & Pedersen, M. B. (2017).
High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas.
Blood,
130(Suppl 1), 4079-4079.
Holst, J. M., Plesner, T. L., Pedersen, M. B., Ludvigsen, M., Frederiksen, H., Møller, M. B., Wang, R., Tam, W., Inghirami, G.
& d'Amore, F. A. (2017).
Lympho- and Myeloproliferative Malignancies Occurring in the Same Host: Description of a Nationwide Discovery Cohort.
Blood,
130(Suppl 1), 1525-1525.
Holst, J. M., Plesner, T. L.
, Pedersen, M. B., Frederiksen, H., Møller, M. B.
, Clausen, M. R., Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P.
, Eberlein, T. R., Mortensen, B. K., Mathiasen, G., Øvlisen, A., Wang, R., Wang, C., Zhang, W.
, Ommen, H. B., Stentoft, J. ... d'Amore, F. (2020).
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Haematologica,
105(10), 2432-2439.
https://doi.org/10.3324/haematol.2019.225839
Holst, J. M., Ludvigsen, M., Hamilton-Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B.
, Steiniche, T., Rabinovich, G. A.
, d'Amore, F. & Pedersen, M. B. (2020).
High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.
Hematological Oncology,
38(1), 59-66.
https://doi.org/10.1002/hon.2702
Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R., Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L.
, Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021).
Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia.
Cancers,
13(21), Article 5526.
https://doi.org/10.3390/cancers13215526
Holst, J. M., Enemark, M. B., Plesner, T. L.
, Pedersen, M. B., Ludvigsen, M. & d'Amore, F. (2021).
Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Case Reports in Hematology,
2021, Article 6623706.
https://doi.org/10.1155/2021/6623706
Holst, J. M., Pedersen, M. B., Enemark, M. B., Hansen, M. C., Noerhave, P. R., Plesner, T. L.
, Frederiksen, H., Moeller, M. B.
, Hamilton-Dutoit, S. J., Noergaard, P., Mortensen, B. K.
, Ommen, H. B., Stentoft, J., Tam, W.
, Ludvigsen, M., Chan, W. C.
, Birkbak, N. J., Inghirami, G.
& d’Amore, F. (2024).
Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.
Haematologica,
109(12), 4067-4072.
https://doi.org/10.3324/haematol.2023.283798
Hollander, P.
, Kamper, P., Smedby, K., Enblad, G.
, Ludvigsen, M., Mortensen, J., Amini, RM.
, Hamilton Dutoit, S. J., d'Amore, F. A., Molin, D. & Glimelius, I. (2017).
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.
Blood Advances,
1(18), 1427-1439.
https://doi.org/10.1182/bloodadvances.2017006346Hohloch, K., Lorsbach, M., Windemuth-Kieselbach, C., Gomez-Codina, J., Likesch, W., Jurczak, W., Cacchione, R., Suh, C., Johnsen, AR.
, D'Amore, F. A., Decaudin, D., Zinzani, PL. & Trümper, L. (2011).
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: Registry analysis of 1100 patients by the international Radioimmunotherapy network (RIT-N).
Journal of Nuclear Medicine,
52(9), 1354-1360.
Hershenfeld, S. A., Tobin, J. W. D., Shelton, V., Calvente, L., Lajkosz, K., Liu, T., Brodtkorb, M.
, d'Amore, F. A., Ludvigsen, M., Baetz, T., LeBrun, D., Johnson, N., Crump, M., Hong, M., Kuruvilla, J., Tremblay-LeMay, R., MacManus, M., Tsang, R., Hodgson, D. C. ... Kridel, R. (2024).
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy.
British Journal of Haematology,
205(5), 1810-1814.
https://doi.org/10.1111/bjh.19698Herek, T. A., Bouska, A., Lone, W., Sharma, S., Amador, C., Heavican, T. B., Li, Y., Wei, Q., Jochum, D., Greiner, T. C., Smith, L., Pileri, S., Feldman, A. L., Rosenwald, A., Ott, G., Lim, S. T., Ong, C. K., Song, J., Jaffe, E. S. ... Iqbal, J. (2022).
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood,
140(11), 1278-1290.
https://doi.org/10.1182/blood.2021015019Hemmingsen, J. K., Enemark, M. H., Sørensen, E. F., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R.
, Honoré, B. & Ludvigsen, M. (2024).
Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma.
Cancers,
16(19), Article 3278.
https://doi.org/10.3390/cancers16193278
Hemmingsen, J. K., Enemark, M. B. H., Sørensen, E. F., Dohrmann, C., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R.
, Honoré, B. & Ludvigsen, M. (2025).
Proteomic Profiling of Limited-Stage Follicular Lymphoma Reveals Differentially Expressed Proteins Linked to Disease Progression Post-Radiation Therapy.
International Journal of Molecular Sciences (Online),
26(19), Article 9306.
https://doi.org/10.3390/ijms26199306
Hemmingsen, J. K., Enemark, M. H., Pedersen, A. K., Sørensen, E. F., Lauridsen, K. L., Løhde, J. B., d’Amore, F., Hamilton-Dutoit, S. J., Bjerre, M. & Ludvigsen, M. (2025).
Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies.
International Journal of Molecular Sciences ,
26(23), Article 11248.
https://doi.org/10.3390/ijms262311248
Heavican, T. B., Bouska, A., Yu, J., Lone, W. G., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., Greiner, T. C., Vose, J., Weisenburger, D. D., Lachel, C., Wang, C., Fu, K., Stevens, J., Lim, S. T., Ong, C. K. ... Iqbal, J. (2019).
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Blood,
133(15), 1664-1676.
https://doi.org/10.1182/blood-2018-09-872549Haraldsdóttir, H., Brøndum, R. F.
, Enemark, M. B. H., Honoré, B., Ludvigsen, M., Aboo, C., Stensballe, A.
, Jørgensen, J. M., Due, H. & Dybkær, K. (2025).
Proteomic Study of Diffuse Large B-Cell Lymphoma Identifying Proteins Associated with R-CHOP Response.
Biomedicines,
13(11), Article 2709.
https://doi.org/10.3390/biomedicines13112709Hansen, G. A. W., Ludvigsen, M., Jacobsen, C., Cangemi, C., Rasmussen, L. M., Vorum, H.
& Honoré, B. (2015).
Fibulin-1C, C1 esterase inhibitor and glucose regulated protein 75 interact with the CREC proteins, calumenin and reticulocalbin.
PLoS One,
10, Article e0132283.
Hansen, J. J.
, Beier Ommen, H., Gormsen, L. C., d'Amore, F. A. & Hjørnet Kamper, P. M. (2018).
Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes.
Case Reports in Hematology,
2018, Article 3726593.
https://doi.org/10.1155/2018/3726593Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Pittaluga, S., Jaffe, E. & Wilson, W. H. (2012).
Alemtuzumab (ALZ) in combination with Dose-Adjusted EPOC (DA-EPOCH) has higher efficacy in nodal than in extranodal or leukemic peripheral T-cell lymphoma.
International Journal of Clinical Oncology.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Maryalice, S. S., Pittaluga, S., Jaffe, E. S. & Wilson, W. H. (2012).
Efficacy of alemtuzumab (ALZ) in combination with dose-ajusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma.
Journal of Clinical Oncology,
30(15).
Gormsen, L. C., Wassberg, C., Molin, D., Kamper, P. M. H., Enblad, G.
& D'Amore, F. A. (2014).
Diffusely increased bone marrow 18F-FDG uptake is an independent predictor of focal bone lesions in patients with newly diagnosed classical Hodgkin Lymphoma.
Blood,
124(21).
Gisselbrecht, C., Borchmann, P.
, D'Amore, F., Illidge, T. M. & Zinzani, P. L. (2014).
Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas.
Leukemia Research,
38(9), 1003.
https://doi.org/10.1016/j.leukres.2014.08.013Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C. M., Caligaris-Cappio, F., Stilgenbauer, S., Marcus, R., Trneny, M., Dreger, P., Montserrat, E., Dreyling, M., Agostinelli, C., Arcaini, L., Campo, E. ... Zucca, E. (2013).
Esmo Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
Annals of Oncology,
24(3), 561-76.
Gang, AO., Stroem, C., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mortensen, L. S., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2012).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology,
23(1), 147-153.
https://doi.org/10.1093/annonc/mdr058Gang, AO., Pedersen, M.
, D'Amore, F. A., Møller-Pedersen, L., Pedersen, BA., Jensen, P., Pedersen, BB., Møller, MB., Gadeberg, O. V., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S., Klausen, TW. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO.
Blood,
120(21).
Gang, AO., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2013).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. An updated analysis with 5 years median follow-up of the population-based investigation from the Danish Lymphoma Group.
Hematological Oncology (Online),
31(suppl 1), 167-168.
https://doi.org/10.1002/hon.2058Gang, A. O., Pedersen, M.
, d'Amore, F., Pedersen, L. M., Jensen, B. A.
, Jensen, P., Møller, M. B., Mourits-Andersen, H. T.
, Pedersen, R. S., Klausen, T. W. & de N Brown, P. (2015).
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Leukemia & Lymphoma,
56(9), 2556-2562.
https://doi.org/10.3109/10428194.2015.1010078Fischer, A., Albert, T. K., Moreno, N., Interlandi, M., Mormann, J., Glaser, S., Patil, P., de Faria, F. W., Richter, M., Verma, A., Balbach, S. T., Wagener, R., Bens, S., Dahlum, S., Göbel, C., Münter, D., Inserte, C., Graf, M., Kremer, E. ... Kerl, K. (2024).
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.
Nature Communications,
15(1), 8571. Article 8571.
https://doi.org/10.1038/s41467-024-52826-0Eyre, T. A., Cwynarski, K.
, d’Amore, F., de Leval, L., Dreyling, M., Eichenauer, D. A., Ferreri, A. J. M., Giné, E., Kersten, M. J., Ladetto, M., Specht, L., Thieblemont, C., Walewski, J., Zucca, E. & Jerkeman, M. (2025).
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology,
36(11), 1263-1284.
https://doi.org/10.1016/j.annonc.2025.07.014Enemark, M. B., Hybel, T. E., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’amore, F. & Ludvigsen, M. (2022).
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.
Cancers,
14(5), Article 1316.
https://doi.org/10.3390/cancers14051316